Catalyst Operating Income from 2010 to 2026
| CPRX Stock | USD 25.00 0.70 2.88% |
Operating Income | First Reported 2004-03-31 | Previous Quarter 66.3 M | Current Value 66.3 M | Quarterly Volatility 19.1 M |
Check Catalyst Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Catalyst Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 5 M, Other Operating Expenses of 358.2 M or Operating Income of 235.6 M, as well as many indicators such as Price To Sales Ratio of 5.49, Dividend Yield of 0.0 or PTB Ratio of 3.71. Catalyst financial statements analysis is a perfect complement when working with Catalyst Pharmaceuticals Valuation or Volatility modules.
Catalyst | Operating Income | Build AI portfolio with Catalyst Stock |
The evolution of Operating Income for Catalyst Pharmaceuticals provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Catalyst Pharmaceuticals compares to historical norms and industry peers.
Latest Catalyst Pharmaceuticals' Operating Income Growth Pattern
Below is the plot of the Operating Income of Catalyst Pharmaceuticals over the last few years. Operating Income is the amount of profit realized from Catalyst Pharmaceuticals operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Catalyst Pharmaceuticals is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Catalyst Pharmaceuticals' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Catalyst Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
Catalyst Operating Income Regression Statistics
| Arithmetic Mean | 49,363,212 | |
| Coefficient Of Variation | 181.65 | |
| Mean Deviation | 70,586,419 | |
| Median | (255,945) | |
| Standard Deviation | 89,669,672 | |
| Sample Variance | 8040.7T | |
| Range | 270.9M | |
| R-Value | 0.83 | |
| Mean Square Error | 2608.4T | |
| R-Squared | 0.70 | |
| Significance | 0.000031 | |
| Slope | 14,812,978 | |
| Total Sum of Squares | 128650.4T |
Catalyst Operating Income History
Other Fundumenentals of Catalyst Pharmaceuticals
Catalyst Pharmaceuticals Operating Income component correlations
Click cells to compare fundamentals
About Catalyst Pharmaceuticals Financial Statements
Catalyst Pharmaceuticals investors use historical fundamental indicators, such as Catalyst Pharmaceuticals' Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Catalyst Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Income | 224.4 M | 235.6 M | |
| Non Operating Income Net Other | 3.3 M | 3.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Catalyst Stock Analysis
When running Catalyst Pharmaceuticals' price analysis, check to measure Catalyst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalyst Pharmaceuticals is operating at the current time. Most of Catalyst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Catalyst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalyst Pharmaceuticals' price. Additionally, you may evaluate how the addition of Catalyst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.